Central Pharmaceutical JSC No. 3 Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
151,915.00
157,003.00
136,489.00
116,488.00
142,959.00
103,575.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-25,679.00
0.00
0.00
0.00
0.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
108,769.00
166,310.00
116,110.00
96,664.00
132,916.00
70,351.00
Cash Flow from Investing Activities
-28,182.00
-118,296.00
-69,874.00
-42,282.00
-83,242.00
-105,615.00
Cash Flow from Financing Activities
-72,255.00
-63,747.00
-49,857.00
-70,585.00
-63,260.00
45,392.00
Net Cash Inflow / Outflow
8,331.00
-15,730.00
-3,595.00
-16,216.00
-13,590.00
10,127.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
2.00
25.00
-12.00
-3.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in VND Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Central Pharmaceutical JSC No. 3
Figures in Million
consolidated Cash Flow Results
Change(VND)
Change(%)
Profit Before Tax
151915.020429
324640.661378
-1,72,725.00
-53.21%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-25679.100967
-158763.242086
1,33,084.00
83.83%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
108769.251339
189767.309031
-80,998.00
-42.68%
Cash Flow from Investing Activities
-28182.057896
-193121.409984
1,64,939.00
85.41%
Cash Flow from Financing Activities
-72255.9871
-155542.528037
83,287.00
53.55%
Net Cash Inflow / Outflow
8331.481086
-158788.386012
1,67,119.00
105.25%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.274743
108.242978
-108.00
-99.75%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -34.60% vs 43.23% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
1,08,769.25
1,66,310.70
-34.60%






